Litcius/Paper detail

Protein Biomarkers in Glaucoma: A Review

Ewa Fiedorowicz, Anna Cieślińska, Patrycja Kuklo, Andrzej Grzybowski

2021Journal of Clinical Medicine17 citationsDOIOpen Access PDF

Abstract

Glaucoma is a multifactorial disease. Early diagnosis of this disease can support treatment and reduce the effects of pathophysiological processes. A significant problem in the diagnosis of glaucoma is limited access to the tested material. Therefore, intensive research is underway to develop biomarkers for fast, noninvasive, and reliable testing. Biomarkers indicated in the formation of glaucoma include chemical compounds from different chemical groups, such as proteins, sugars, and lipids. This review summarizes our knowledge about protein and/or their protein-like derived biomarkers used for glaucoma diagnosis since 2000. The described possibilities resulting from a biomarker search may contribute to identifying a group of compounds strongly correlated with glaucoma development. Such a find would be of great importance in the diagnosis and treatment of this disorder, as current screening techniques have low sensitivity and are unable to diagnose early primary open-angle glaucoma.

Topics & Concepts

MedicineGlaucomaBiomarkerDiseaseBiomarker discoveryIntensive care medicineBioinformaticsOphthalmologyPathologyProteomicsBiochemistryChemistryGeneBiologyGlaucoma and retinal disordersRetinal Diseases and TreatmentsFlavonoids in Medical Research
Protein Biomarkers in Glaucoma: A Review | Litcius